We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Reliance Gen. | LSE:GMX | London | Ordinary Share | GB00B1MM9925 | ORD 10P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.55 | 0.00 | 00:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
From Jan 2020 to Jan 2025
TIDMGMX
RNS Number : 6322K
Reliance GeneMedix PLC
19 July 2011
FOR IMMEDIATE RELEASE 19 July 2011
Reliance GeneMedix plc
(AIM: GMX)
Reliance GeneMedix plc (the "Company"), the AIM listed biopharmaceutical company, announces that it has entered into a further loan agreement with its parent company, Reliance Life Sciences ("RLS"). This further loan is in addition to that announced by the Company on 24 December 2009 and its principal terms are as follows:
-- Total amount: Up to EUR10 million
-- Drawdown period: Up to 31 March 2013
-- Interest: 7 per cent. per annum
-- Type: Unsecured
-- Repayment: In three equal installments on 31 March 2014, 2015 and 2016
The independent directors of the Company, namely Dr. R. A. Mashelkar, Mr Dileep Choksi and Mr Atul Dayal consider, having consulted with the Company's nominated adviser, that the terms of the above transaction are fair and reasonable insofar as the Company's shareholders are concerned.
In accordance with AIM Rule 26, a copy of this announcement is available on the Company's website at www.genemedix.com.
ENQUIRIES:
Reliance GeneMedix plc Tel: +353 57 932 3572
Vinay Ranade, Chief Executive Officer
Deloitte Corporate Finance Tel: +44 (0)20 7936 3000
Jonathan Hinton, John Ball
Lothbury Financial Services Limited Tel: +44 (0)20 7868 2567
Michael Padley
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCSFISWUFFSEEW
1 Year Reliance Genemedix Chart |
1 Month Reliance Genemedix Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
